Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Article 35
December 17, 2025: Federal Litigation Created for People Who Lost Their Vision After Taking Ozempic On December 15, 2025, the Joint Panel on Multidistrict Litigation (JPML) approved a request to consolidate lawsuits filed by people who experienced vision loss after taking Ozempic and other GLP-1 drugs
The principal medication in this protocol belongs to the GLP-1 agonists group
Constipation Constipation may be from reduced food intake or change in diet as well as slower gut motility
Behavioral adjustments become necessary as appetite changes
In June last year, Hansoh licensed the experimental drug to US biotechnology company Regeneron, granting exclusive development and commercial rights outside Greater China in a deal worth about 2 billion yuan, according to the company
![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
